Form 4 for ARVN ARVINAS, INC.

Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-09 · accession 0001655759-25-000087 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-05-13	2025-05-09	ARVN	Berkowitz Noah	Chief Medical Off	A - Grant	$0.00	+59.6K	169.6K	+54%	$0
D	2025-05-13	2025-05-09	ARVN	Berkowitz Noah	Chief Medical Off	A - Grant	$0.00	+91.0K	91.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-05-09	A	A	59,600	$0.00	169,623	D	—	—	(F1) The restricted stock units (each, an "RSU") were granted by the issuer on May 9, 2025, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
2	Derivative	Stock Option (right to buy)	2025-05-09	A	A	91,000	$0.00	91,000	D	$6.61 · — to 2035-05-08	91,000 Common Stock	(F2) The option was granted by the Issuer on May 9, 2025, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.